| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 04/14/2010 | CN101693702A Technology for producing N-formylpiperidine |
| 04/14/2010 | CN101693692A Hybrid ionic liquid hydrate, preparation process and application thereof |
| 04/14/2010 | CN101693670A Benzoic acid nitrogen mustard derivative as well as preparation method and application thereof |
| 04/14/2010 | CN101230023B Method for preparing azo onium diol sodium salt |
| 04/13/2010 | USRE41226 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 04/13/2010 | US7696247 Lipid-based nitric oxide donors |
| 04/13/2010 | US7696231 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 04/13/2010 | CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/08/2010 | WO2010039256A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 04/08/2010 | WO2010038837A1 Photosensitive resin composition, article using same, and method for forming negative pattern |
| 04/08/2010 | WO2010038828A1 N-(α-AROMATIC GROUP-SUBSTITUTED-2-NITRO-4,5-DIALKOXYBENZYLOXYCARBONYL)AMINE COMPOUND AND METHOD FOR PRODUCING SAME |
| 04/08/2010 | WO2009053763A8 New non-peptide derivatives as bradykinin b1 antagonists |
| 04/08/2010 | US20100087479 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 04/08/2010 | US20100084257 Method for the continuous separation of mixtures comprising morpholine (mo), monoaminodiglycol (adg), ammonia and water by means of distillation |
| 04/08/2010 | CA2738768A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 04/07/2010 | EP2172463A1 Quaternary ammonium salt, electrolytic solution and electrochemical device |
| 04/07/2010 | EP2170853A1 N- ( (3, 5-dichlorophenyl) methyl) -2- u-methyl-1-piperazinyl) -2- ( 1-naphtalenyl) ethan amide as ghrelin receptor modulator |
| 04/07/2010 | EP2170824A1 Novel process |
| 04/07/2010 | EP2170822A2 Proton acceptor iminium/carbocation-type coupling agents |
| 04/07/2010 | EP2170814A2 Antibacterial agents |
| 04/07/2010 | EP2170807A1 Spiro compounds useful as antagonists of the h1 receptor |
| 04/07/2010 | EP2079718B1 Method for the continuous separation of mixtures comprising morpholine (mo), monoaminodiglycol (adg), ammonia, and water by means of distillation |
| 04/07/2010 | EP1948607B1 Cyclopropyl amines as modulators of the histamine h3 receptor |
| 04/07/2010 | EP1590340B1 Inhibitors of histone deacetylase |
| 04/07/2010 | EP1530470B9 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 04/06/2010 | US7691904 Diisopropylphenyl esters of N-amino- or N-heterocyclyl-alkanamic acids, e.g., N-(2-Piperidin-1-yl-ethyl)-succinamic acid 2,6-diisopropylphenyl ester; induction and maintenance of anesthesia or sedation as well as treating cancer, nervous system disorders and respiratory system disorders, |
| 04/06/2010 | US7691849 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 04/06/2010 | US7691837 e.g. 1-{[1,5-bis(4-cholorophenyl)-2-methylpyrrol-3-yl]methyl}-4-(4-fluoro-phenyl)piperazine; Mycobacterium tuberculosis, drug resistant Mycobacterium tuberculosis, Mycobacterium avium-intracellulare complex, Mycobacterium fortuitum or Mycobacterium kansasi |
| 04/06/2010 | CA2530814C Quaternary ammonium salt, electrolyte, and electrochemical device |
| 04/06/2010 | CA2513738C Casr antagonist |
| 04/01/2010 | US20100081806 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 04/01/2010 | US20100081660 Novel Compounds Having Selective Inhibiting Effect at GSK3 |
| 03/31/2010 | EP2168961A1 Process for producing macrolide compound and intermediate therefor |
| 03/31/2010 | EP2167509A1 Piperazine and ý1,4¨diazepan derivatives as nk antagonists |
| 03/31/2010 | EP2167485A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 03/31/2010 | EP2167480A2 Cationic lipids compositions and methods for enhancing immune responses to vaccines |
| 03/31/2010 | EP2167479A1 Process for preparation of substantially optically pure levorotatory and dextrorotatory enantiomers of cetirizine using novel intermediates |
| 03/31/2010 | EP2167466A1 N-phenyl hydrazides as modulators of the ghrelin receptor |
| 03/31/2010 | EP1807393B1 Diarylsulfones as 5-ht2a antagonists |
| 03/31/2010 | EP1620091B1 Inhibitors of glutaminyl cyclase |
| 03/31/2010 | CN101687775A Aldimines and compositions comprising aldamine |
| 03/31/2010 | CN101687773A Substituted 2- [2- (phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators |
| 03/31/2010 | CN101684109A Method for producing dodecyl morpholine by suspension method |
| 03/31/2010 | CN101684084A Tetracycline compounds containing carbamido |
| 03/31/2010 | CN101684083A Guanidinoalkanoylamino substituted tetracycline derivatives |
| 03/30/2010 | US7687624 Process for the production of N-arylmorpholinones |
| 03/30/2010 | US7687536 Aminocycloalkyl cinnamide compounds for arrhythmia and as analgesics and anesthetics |
| 03/30/2010 | US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders; |
| 03/30/2010 | US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders |
| 03/30/2010 | CA2457444C 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 03/30/2010 | CA2423631C 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 03/30/2010 | CA2360685C Methods for restoring and/or enhancing accommodation in pseudo phakia |
| 03/25/2010 | WO2010032258A1 Aryl sulfonamide amine compounds and their use as 5-ht6 ligands |
| 03/25/2010 | WO2010032010A1 Aryl-phenyl-sulfonamide-phenylene compounds and their use |
| 03/25/2010 | WO2010032009A1 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use |
| 03/25/2010 | WO2010031719A1 Method for the continuous production of an amine using an aluminium-copper catalyst |
| 03/25/2010 | WO2009146539A8 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
| 03/25/2010 | US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics |
| 03/25/2010 | US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 03/25/2010 | US20100075929 9-aminoacyl tetracycline compounds and methods of use thereof |
| 03/25/2010 | CA2737282A1 Aryl sulfonamide amine compounds and their use as 5-ht6 ligands |
| 03/25/2010 | CA2736980A1 Aryl-phenyl-sulfonamide-phenylene compounds and their use |
| 03/25/2010 | CA2736971A1 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use |
| 03/24/2010 | EP2164838A1 Novel compound |
| 03/24/2010 | EP2164837A1 Novel compounds |
| 03/24/2010 | EP2164836A2 Method for the preparation of lasofoxifene and crystalline intermediates used therein |
| 03/24/2010 | CN101679457A Piperazine and [1,4] diazepan derivatives as NK antagonists |
| 03/24/2010 | CN101679331A 环己基衍生物 Cyclohexyl derivative |
| 03/24/2010 | CN101679330A metabolites of (thio)carbamoyl-cyclohexane derivatives |
| 03/24/2010 | CN101679329A compositions of tolperisone |
| 03/24/2010 | CN101679267A Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative |
| 03/24/2010 | CN101679261A Piperazine and piperidine mglur5 potentiators |
| 03/24/2010 | CN101678019A piperidine/piperazine derivatives |
| 03/24/2010 | CN101678013A piperidine/piperazine derivatives |
| 03/24/2010 | CN101676276A Method for preparing N-tert-butyloxycarbonylpiperazine acetic acid hydrochloride |
| 03/23/2010 | US7683053 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 03/23/2010 | US7683035 Method of stabilizing and/or isolating nucleic acids |
| 03/23/2010 | CA2418652C Novel 3-substituted urea derivatives and medicinal use thereof |
| 03/18/2010 | WO2010029436A2 Novel solid state forms of ranolazine salts |
| 03/18/2010 | WO2010029379A1 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases |
| 03/18/2010 | WO2010028840A1 2-ethoxy benzoic acid derivative |
| 03/18/2010 | WO2010028776A1 Piperazine derivatives for binding and imaging amyloid plaques and their use |
| 03/18/2010 | WO2009024823A8 Cyclopropyl amide derivatives |
| 03/18/2010 | US20100069630 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same |
| 03/18/2010 | US20100069453 Certain Chemical Entities, Compositions, and Methods |
| 03/18/2010 | US20100069403 Methods for preventing or treating cardiac arrhythmia |
| 03/18/2010 | US20100069389 Novel forms of reboxetine |
| 03/18/2010 | US20100069378 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 03/18/2010 | US20100069328 Novel ortho-aminoanilides for the treatment of cancer |
| 03/18/2010 | US20100068272 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors |
| 03/18/2010 | US20100068138 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 03/18/2010 | CA2736530A1 Piperazine derivatives for binding and imaging amyloid plaques and their use |
| 03/17/2010 | EP2163541A1 Piperazine derivatives for binding and imaging amyloid plaques and their use |
| 03/17/2010 | EP1840124B1 Quaternary ammonium salt, electrolyte, electrolyte solution and electrochemical device |
| 03/17/2010 | CN101671317A Preparation method of Naftopidil |
| 03/17/2010 | CN101671316A Ion liquid based on morpholine cations and preparation method thereof |
| 03/16/2010 | US7678834 Substituted 4-aminocyclohexanol compounds |
| 03/16/2010 | US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 03/16/2010 | US7678826 Antagonists of the G-protein-coupled chemoattractant receptor CRTh2; {4-Chloro-2-[5-chloro-2-(1-methyl-2-oxo-2-pyrrolidin-1-yl-ethoxy)-benzyl]-phenoxy}-acetic acid for example; asthma and obstructive airways diseases for example |
| 03/16/2010 | US7678583 Method of lysis of erythrocytes |